carbidopa

(redirected from Levocarb CR)
Also found in: Dictionary.
Related to Levocarb CR: Levodopa-carbidopa, Sinemet, Sinemet cr

carbidopa

 [kahr-bĭ-do´pah]
an inhibitor of the decarboxylation of levodopa in peripheral tissues; it does not cross the blood-brain barrier and is used in combination with levodopa to control the symptoms of parkinson's disease. In the presence of carbidopa, levodopa enters the brain in larger quantities, thus avoiding the need for excessively high doses of levodopa.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

car·bi·do·pa

(kar'bi-dō'pă),
A dopa decarboxylase inhibitor that does not enter the brain used in conjunction with levodopa in the treatment of Parkinson disease to reduce L-dopa dosage and mitigate side effects.
Farlex Partner Medical Dictionary © Farlex 2012

carbidopa

(kär′bĭ-dō′pə)
n.
A drug, C10H14N2O4, that increases the availability of L-dopa to the brain and is administered with L-dopa to treat Parkinson's disease.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.

car·bi·do·pa

(kahr'bi-dō'pă)
A dopa decarboxylase inhibitor that does not enter the brain used in conjunction with levodopa in the treatment of parkinsonism to reduce L-dopa dosage and mitigate side effects.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012

carbidopa

A drug that prevents the breakdown of the drug levodopa in the body and thus enhances its action in PARKINSON'S DISEASE. See also BENSERAZIDE. A brand name is Sinemet.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005